Genotype is Associated with Left Ventricular Reverse Remodelling and Early Events in Recent-Onset Dilated Cardiomyopathy
ESC Heart Failure · 01.12.2024 · 11 (6) · 4127-4138
DOI: 10.1002/ehf2.15009 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 11.08.2024. Verfasst von Milos Kubanek und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Ventricular Remodeling, Genotype. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health of the Czech Republic, Charles University Institutional Programmes, Czech National Center for Medical Genomics.
Abstract (Originalsprache)
Aims
Recent-onset dilated cardiomyopathy (RODCM) is characterized by heterogeneous aetiology and diverse clinical outcomes, with scarce data on genotype–phenotype correlates. Our aim was to correlate individual RODCM genotypes with left ventricular reverse remodelling (LVRR) and clinical outcomes. Methods and results In this prospective study, a total of 386 Czech RODCM patients with symptom duration ≤6 months underwent genetic counselling and whole-exome sequencing (WES). The presence of pathogenic (class 5) or likely pathogenic (class 4) variants in a set of 72 cardiomyopathy-related genes was correlated with the occurrence of all-cause death, heart transplantation, or implantation of a ventricular assist device (primary outcome) and/or ventricular arrhythmia event (secondary outcome). LVRR was defined as an improvement of left ventricular ejection fraction to >50% or ≥10% absolute increase, with a left ventricular end-diastolic diameter ≤33 mm/m2 or ≥10% relative decrease. Median follow-up was 41 months. RODCM was familial in 98 (25%) individuals. Class 4–5 variants of interest (VOIs) were identified in 125 (32%) cases, with 69 (18%) having a single titin-truncating variant (TTNtv) and 56 (14%) having non-titin (non-TTN) VOIs. The presence of class 4–5 non-TTN VOIs, but not of TTNtv, heralded a lower probability of 12-month LVRR and proved to be an independent baseline predictor both of the primary and the secondary outcome. The negative result of genetic testing was a strong protective baseline variable against occurrence of life-threatening ventricular arrhythmias. Detection of class 4–5 VOIs in genes coding nuclear envelope proteins was another independent predictor of both study outcomes at baseline and also of life-threatening ventricular arrhythmias after 12 months. Class 4–5 VOIs of genes coding cytoskeleton were associated with an increased risk of life-threatening ventricular arrhythmias after baseline assessment. A positive family history of dilated cardiomyopathy alone only related to a lower probability of LVRR at 12 months and at the final follow-up.
Conclusions
RODCM patients harbouring class 4–5 non-TTN VOIs are at higher risk of progressive heart failure and life-threatening ventricular arrhythmias. Genotyping may improve their early risk stratification at baseline assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart, ERN GUARD-Heart, IKEM, Prague, Czech Republic.
- Institute of Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Research Unit for Rare Diseases, Charles University, Prague, Czech Republic.
- Department of Cardiovascular Medicine, Second Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- First Internal Clinic of Cardio-Angiology, St. Anne's University Hospital and Medical School of Masaryk University, Brno, Czech Republic.
ORCID-Profile: Milos Kubanek
Förderung
- Ministry of Health of the Czech Republic
- Charles University Institutional Programmes
- Czech National Center for Medical Genomics
- European Union, Next Generation EU, National Institute for Research of Metabolic and Cardiovascular Diseases (Program Exceles)
- Ministerstvo Zdravotnictví Ceské Republiky
Zitieren
APA
Kubanek, M., Binova, J., Piherova, L., Krebsova, A., Kotrc, M., Hartmannova, H., Hodanova, K., Musalkova, D., Stranecky, V., Palecek, T., Chaloupka, A., Grochova, I., Krejci, J., Petrkova, J., Melenovsky, V., Kmoch, S., & Kautzner, J. (2024). Genotype is Associated with Left Ventricular Reverse Remodelling and Early Events in Recent-Onset Dilated Cardiomyopathy. ESC Heart Failure, 11(6), 4127-4138. https://doi.org/10.1002/ehf2.15009
Vancouver
Kubanek M, Binova J, Piherova L, Krebsova A, Kotrc M, Hartmannova H, et al. Genotype is Associated with Left Ventricular Reverse Remodelling and Early Events in Recent-Onset Dilated Cardiomyopathy. ESC Heart Failure. 2024;11(6):4127-4138. doi:10.1002/ehf2.15009
BibTeX
@article{Kubanek2024,
author = {Kubanek, Milos and Binova, Jana and Piherova, Lenka and Krebsova, Alice and Kotrc, Martin and Hartmannova, Hana and Hodanova, Katerina and Musalkova, Dita and Stranecky, Viktor and Palecek, Tomas and Chaloupka, Anna and Grochova, Ilga and Krejci, Jan and Petrkova, Jana and Melenovsky, Vojtech and Kmoch, Stanislav and Kautzner, Josef},
title = {Genotype is Associated with Left Ventricular Reverse Remodelling and Early Events in Recent-Onset Dilated Cardiomyopathy},
journal = {ESC Heart Failure},
year = {2024},
volume = {11},
number = {6},
pages = {4127--4138},
doi = {10.1002/ehf2.15009}
}
EUVIMED